Dana-Farber Cancer Institute
The Robert G. Fenley Writing Awards: Basic Science Staff Writing
Gold
Dana-Farber scientists are known for their clinical and translational investigations, but the Institute also has many basic science laboratories making discoveries that have shaped anti-cancer interventions used in the clinic today. This story chronicles a success story, from the earliest basic science, through translational and clinical research, and finally to the experiences of a patient who is benefitting from a novel therapeutic, a CDK4/6 inhibitor for metastatic breast cancer, that emerged from the science.
What was the most impactful part of your entry?
The most amazing part of this story is that of the patient, Kathleen, who has survived and thrived through multiple cancer diagnoses, clinical trials, and therapies. She is brave and full of energy and reflects on science in a way that helps readers see and feel how important science is in the effort to advance cancer therapy.
What is one thing you learned from your entry/experience?
This story has many moving parts and storylines, and a key challenge was managing timelines and transitions.
Contact: Elizabeth Dougherty
elizabeth_dougherty@dfci.harvard.edu